Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2535 Target Snapshot

Solute carrier family 2, facilitated glucose transporter member 1 · SINGLE PROTEIN · Homo sapiens

14,105Compounds
157Assays
1Approved Drugs
1,426.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P11166. Use UniProt P11166 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P11166 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Solute carrier family 2, facilitated glucose transporter member 1 as ChEMBL target CHEMBL2535, mapped to UniProt P11166. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Solute carrier family 2, facilitated glucose transporter member 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2535
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P11166
Solute carrier family 2, facilitated glucose transporter member 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Solute carrier family 2, facilitated glucose transporter member 1 is the right protein anchor across sources, using UniProt P11166 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSolute carrier family 2, facilitated glucose transporter member 1
UniProt AccessionP11166
Component TypeProtein
Sequence Length492 aa

Solute carrier family 2, facilitated glucose transporter member 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Solute carrier family 2, facilitated glucose transporter member 1, mapped to UniProt P11166. Sequence length is 492 aa.

Mapped IDP11166
Review nameSolute carrier family 2, facilitated glucose transporter member 1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
3
Phase II
2
Phase I
Assay Mix

Activity Type Distribution

IC501,395.0
KI9.0
EC501.0
KD21.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5661873 9.52 IC50 0.3 Preclinical
CHEMBL3780239 9.0 IC50 1.0 Preclinical
CHEMBL5661842 9.0 IC50 1.0 Preclinical
CHEMBL5661847 9.0 IC50 1.0 Preclinical
CHEMBL5661848 9.0 IC50 1.0 Preclinical
CHEMBL4448899 8.7 IC50 2.0 Preclinical
CHEMBL5661896 8.7 IC50 2.0 Preclinical
CHEMBL5661910 8.7 IC50 2.0 Preclinical
CHEMBL5661838 8.52 IC50 3.0 Preclinical
CHEMBL5661843 8.52 IC50 3.0 Preclinical
Distribution

pChEMBL Value Distribution

351
5.0
137
5.5
60
6.0
42
6.5
33
7.0
24
7.5
29
8.0
12
8.5
4
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

Assay Landscape

Assay Landscape

157
Total Assays
439
Tested Compounds
3
Assay Types
Binding — 129 assays, 325 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 107 299 6.0
single protein format 7 6 6.2
assay format 6 12 6.5
tissue-based format 5 0
cell membrane format 4 8 5.7
ADME — 24 assays, 16 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 23 16 4.8
mitochondrion format 1 0
Functional — 4 assays, 439 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 436 5.4
cell-based format 1 3 6.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine